Scope
ISO 9614-2:2023
Sound Power — Intensity Method (Scanning)
This scanning-based intensity method continuously measures sound intensity as the probe moves across a measurement surface, enabling rapid acoustic mapping and source characterization without requiring discrete point measurements. The scanning approach is faster and provides superior spatial resolution for identifying noise sources and evaluating acoustic modifications. It works effectively in non-ideal acoustic environments including semi-reverberant or open spaces. Accreditation guarantees proper probe calibration, scanning patterns, and data integration methods meet international standards.
What it measures
- Sound intensity distribution across measurement surface
- Sound power level (Lw) by continuous surface integration
- Frequency-weighted and A-weighted acoustic power
- Acoustic source maps and noise radiation patterns
🇩🇪
DIN EN ISO 9614-1
🇬🇧
BS EN ISO 9614-1
🇫🇷
NF EN ISO 9614-1
🇮🇹
UNI EN ISO 9614-1
🇪🇸
UNE EN ISO 9614-1
🇳🇱
NEN EN ISO 9614-1
🇩🇪
DIN EN ISO 3746
🇬🇧
BS EN ISO 3746
🇫🇷
NF EN ISO 3746
🇮🇹
UNI EN ISO 3746
🇪🇸
UNE EN ISO 3746
🇳🇱
NEN EN ISO 3746
1,670
Accredited labs
18
Countries
Showing 1,551–1,575 of 1,670 labs
Familiäre Adenomatöse Polyposis
Syndrome (APC, MUTYH)
STK11, SMAD4 ), TruRisk® -Panel [SNV, CN
Familiäre Polyposis-Syndrome [FAP]
(APC, MUTYH)
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
alpha-Aminobuttersäure
Mianserin
Arginin
Asparagin
Asparaginsäure
+ 3 more
Candida spp.-Antikörper
Cardiolipin-Antikörper
Meningitiserreger-Ag (E. coli
Staphylococcus aureus
Treponema pallidum-Antikörper
+ 3 more
Granulozytäre Antikörper
(Screening und Differenzierung)
HLA spezifische Antikörper
B-Streptokokken (Screening)
Ektoparasiten (Differenzierung)
+ 3 more
Anti-Thyreoglobulin-Antikörper
[Anti-TG]
Anti-Thyreoperoxidase Antikörper
[Anti-TPO]
Anti-TSH-Rezeptor Antikörper
+ 3 more
angeborener Chromosomensatz
Silver-Russell-Syndrom:
H19, KCNQ1OT1
MEST
Deletion; Angelman-Syndrom
+ 3 more
5-Hydroxyindolessigsäure
Amitriptylin/Nortriptylin
Cyclosporin A
Gesamt-Itraconazol
Metanephrine, Normetanephrine
+ 3 more
IEC 60061-1
IEC 60061-2
IEC 60238
IEC 61184
IEC 60400
+ 3 more
(HSG 248) – 2021
ASB/10 based on HSG 248
(PCM) based on HSG 248
ASB/6 based on HSG 248
BS EN ISO 14644-1:2015
+ 3 more
UNE-EN 60942
UNE-EN 61672-3
UNE 82503
UNE-EN 60804
UNE 20942
+ 3 more
Myopathie, Nemaline (TyP1, 3-10:
ASTM E 23-18
ASTM D 1322
Toxizität UGT1A1-Gen rs3064744, rs414832
DIN EN 1789
+ 3 more
5 a 18 mm/s (Valor pico) (frecuencias en
5 a 12 mm/s (RMS) (frecuencias entre 8 H
VWR International
Active
TEMPERATURE
parameters and ranges)
indicators or recorders
WEIGHING INSTRUMENTS
DIN EN 61466-1
DIN EN 61466-2
DIN 14678
DIN EN 54-2/A1
DIN EN 543
+ 3 more
Vectoflow
Active
am Standort Vectoflow Windtunnel A, Frie
Strömungsgeschwindigkeit
von Gasen 15 m/s bis
> 38 m/s
Blutbild, kleines (Erythrozyten, Leukozy
Erythrozyten
Leukozyten
Retikulozyten
Thrombozyten
+ 3 more
No matching labs found.